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Background: Tumor necrosis factor alpha (TNF-α) plays a central role in the initiation and maintenance of immune
responses to periodontopathic bacteria. However, excess TNF-α leads to dysregulated immune responses and
progression of periodontitis. Porphyromonas gingivalis (P. gingivalis) invades gingival epithelial cells and then
multiplies and survives for a long period. Additionally, increment of TNF-α in periodontal sites is associated with
a high prevalence of gram-negative anaerobes such as P. gingivalis. However, it has not been determined
whether TNF-α affects invasion of P. gingivalis in periodontal tissues.
Results: We examined the effect of TNF-α on invasion of P. gingivalis in gingival epithelial cells and clarified the
mechanism by which TNF-α augments invasion of P. gingivalis. Invasion of P. gingivalis into Ca9-22 cells was augmented
by stimulation with TNF-α and it was inhibited by treatment with an antibody to TNF receptor-1. TNF-α increased
production of ICAM-1, and P. gingivalis invasion was inhibited by an antibody to ICAM-1 in Ca9-22 cells. Silencing of
Rab5 mRNA inhibited P. gingivalis invasion. Furthermore, the JNK inhibitor SP600125 inhibited invasion of P. gingivalis
and also decreased the active form of Rab5 in Ca9-22 cells.
Conclusion: TNF-α augments invasion of P. gingivalis in human gingival epithelial cells through increment of ICAM-1
and activation of Rab5. These phenomena may contribute to persistent infection of P. ginigvalis and prolongation of
immune responses in periodontal tissues.
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Chronic periodontitis is initiated by a bacterial biofilm
commonly called dental plaque, which initiates inflam-
mation that affects the supporting structures of teeth,
leading to bone and eventually tooth loss. The develop-
ment of periodontitis is a multifactorial process involv-
ing interactions between the host and microorganisms
that colonize the gingival sulcus. Porphyromonas gingi-
valis is a gram-negative anaerobe of dental plaque and it
has been strongly implicated in the initiation and pro-
gression of periodontal disease and possesses a sophisti-
cated array of virulence factors, including those that* Correspondence: kmatsu30@ncgg.go.jp
1Department of Oral Disease Research, National Center of Geriatrics and
Gerontology, Obu, Aichi 747-8511, Japan
Full list of author information is available at the end of the article
© 2014 Kato et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.allow the bacterium to adhere to and invade host epithe-
lial cells [1-5]. P. gingivalis invasion is accomplished by
manipulating host signal transduction and remodeling of
the cytoskeletal architecture. However, the molecular
mechanisms used by P. gingivalis to facilitate intern-
alization are only partially understood.
Intracellular bacterial pathogens have evolved highly
specialized mechanisms to enter and survive intracellu-
larly within their eukaryotic hosts. Rabs play an essential
role in both endocytic and exocytic traffic in eukaryotic
cells [6]. Rab5, one of the most studied Rab proteins in
recent years, is involved in early steps of the endocytic
process. Rab5 regulates intracellular membrane traffick-
ing of several pathogens, including Salmonella enterica
serovar Typhimurium [7-9], Mycobacterium spp [10],
and Listeria monocytogenes [11]. Rab5 may also mediated. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 TNF-α augments invasion of P. gingivalis in Ca9-22
cells. (A) Ca9-22 cells were treated with 10 ng/ml of TNF-α for 3 h.
The cells were further incubated with P. gingivalis ATCC 33277 at an
MOI of 100 for 1 h. Media in the cultures were then replaced with
new media containing antibiotics for 1 h. Lysates of the cells with
sterile water were then seeded on horse blood agar plates to determine
the numbers of viable intracellular bacteria (means ± standard deviations
[SD] [n = 3]). **, P< 0.01 versus TNF-α (−). CFU: colony forming units.
(B) Ca9-22 cells were treated with 10 ng/ml of TNF-α for 3 h and
were then incubated with P. gingivalis ATCC 33277 for 1 h. P.gingivalis
was stained using antiserum for P. gingivalis whole cells. Then
localization of P. gingivalis in the cells was observed by a confocal
laser scanning microscope. Each molecule was visualized as follows:
P. gingivalis (red). Bars in each panel are 10 μm.
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little is known about the role of Rab5 in P. gingivalis
invasion.
TNF-α is a potent pleiotropic proinflammatory cyto-
kine and is released by a variety of different cell types in
response to various stimuli, including bacteria, parasites,
viruses, cytokines and mitogens. TNF-α is involved in
systemic and local inflammation due to stimulation of
different signal transduction pathways, inducing the
expression of a broad range of genes. TNF-α regulates
a host response to infection; on the other hand, in-
appropriate expression of TNF-α has detrimental ef-
fects for the host. Deregulation of TNF-α has been
implicated in the pathogenesis of numerous complex
diseases, including periodontitis [12-14], cardiovas-
cular diseases [15,16], diabetes mellitus [17,18], auto-
immune diseases [19,20], and cancer [21,22]. Clinical
studies have shown an upregulation of TNF-α in peri-
odontitis, e.g., in gingival crevicular fluid [23], in gin-
gival tissues [24], and in plasma and serum [14,25].
TNF-α was shown to have an impact on different bio-
logical processes, including induction of inflammatory
mediators, such as matrix metalloproteases (MMPs),
cytokines, chemokines and prostaglandins [26], endo-
thelial cell activation and endothelial-leukocyte inter-
actions [27], monocyte adhesion [28], mediating bone
remodeling [29], and oxidative processes [30]. P. gin-
givalis induces highest levels of TNF-α expression,
followed by IL-1 and IL-6 [31]. However, we have
no information on whether TNF-α affects invasion of
P. gingivalis in periodontal tissues. In the present
study, we examined the effect of TNF-α on invasion
of P. gingivalis in gingival epithelial cells and clarified
the molecular mechanism by which TNF-α augments
invasion of P. gingivalis.
Results
TNF-α augments invasion of P. gingivalis in gingival
epithelial cells
We first examined the effect of TNF-α on invasion of
P. gingivalis in Ca9-22 cells. The cells were treated
with 10 ng/ml of TNF-α for 3 h and were then incu-
bated with P. gingivalis (MOI =100) for 1 h. Invasion
of the cells by P. gingivalis was determined by an in-
vasion assay. Invasion of Ca9-22 cells by P. gingivalis
was observed without TNF-α pretreatment. However,
the invasion was significantly increased by stimulation
with TNF-α (Figure 1A). We also observed localization of
intracellular P. gingivalis in the cells by using a confocal
laser scanning microscope. Z-stack image of the cells
shows the intracellular localization of P. gingivalis. Intra-
cellular P. gingivalis was increased by stimulation with
TNF-α, although a small amount of P. gingivalis was
found without TNF-α pretreatment (Figure 1B).TNF-α-augmented invasion of P. gingivalis is mediated by
TNF receptor-I
The biological effects of TNF-α are transmitted via
two distinct membrane receptors, TNFR-I and TNFR-II
[32,33]. To determine which type of TNFR mediates
P. gingivalis invasion in Ca9-22 cells, we examined
the effects of neutralization of TNFRs on the TNF-α-
augmented invasion of P. gingivalis. We first examined
the expression of TNFR-I and TNFR-II in Ca9-22 cells by
Western blotting. The cells expressed TNFR-I but not
TNFR-II (Figure 2A). We next examined the effects of a
neutralizing anti-TNFR-I mAb on the TNF-α-induced in-
vasion of P. gingivalis in Ca9-22 cells. The cells were pre-
incubated with a mouse monoclonal antibody to TNFR-I
for 1 h. Then the cells were treated with TNF-α prior
to addition of P. gingivalis. The anti-TNFR-I antibody ex-
hibited a significant inhibitory effect on the invasion of P.
Figure 2 TNF-α-augmented invasion of P. gingivalis is mediated
by TNF receptor-I. (A) Expression of TNF receptors on Ca9-22 cells.
Expression of TNF receptors in lysates of the cells was analyzed by
Western blotting with anti-TNFR-I and anti-TNFR-II monoclonal
antibodies. Human monocytic THP-1 cells were used as a positive
control of TNFR-II. (B) Anti-TNFR-I antibody blocked TNF-a-augmented
invasion of P. gingivalis in Ca9-22 cells. Ca9-22 cells were preincubated
with 5 μg/ml of anti-TNFR-I monoclonal antibody or mouse IgG at
37°C for 1 h and were then incubated with TNF-α for 3 h. The cells
were further incubated with P. gingivalis (MOI =100) for 1 h. Viable
P. gingivalis in the cells was determined as described in Methods.
(Means ± standard deviations [SD] [n = 3]). ††, P < 0.01 versus
control + TNF-α (−); **, P < 0.01 versus none + TNF-α (+).
Figure 3 TNF-α augments invasion of P. gingivalis through
synthesis of mRNAs and proteins. Actinomycin D and
cycloheximide inhibited TNF-α-augmented invasion of P. gingivalis in
Ca9-22 cells. Confluent Ca9-22 cells were preincubated with 1 μg/ml
actinomycin D (Act D) or cycloheximide (CHX) at 37°C for 1 h and
were then incubated with TNF-α for 3 h. The cells were further
incubated with P. gingivalis (MOI =100) for 1 h. Viable P. gingivalis
in the cells was determined as described in Methods. (Means ± standard
deviations [SD] [n = 3]). ††, P< 0.01 versus control + TNF-α (−); **, P< 0.01
versus control + TNF-α (+).
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trol mouse IgG antibody did not prevent the augmenta-
tion of P. gingivalis invasion by TNF-α.
TNF-α augments invasion of P. gingivalis through NF-κB
and MAPK pathways
To determine whether mRNA synthesis and protein syn-
thesis were required for P. gingivalis invasion, Ca9-22
cells were preincubated with 1 μg/ml of the RNA poly-
merase II inhibitor actinomycin D or the protein syn-
thesis inhibitor cycloheximide for 1 h and were then
incubated with TNF-α prior to addition of P. gingivalis.
Actinomycin D and cycloheximide exhibited significantinhibitory effects on the invasion of P.gingivalis into Ca9-
22 cells (Figure 3). The PI3K/Akt signaling pathway is
commonly initiated by transmembrane receptor signaling
and controls cellular phagocytic responses through mul-
tiple downstream targets that regulate actin polymerization
and cytoskeletal arrangements at the target site [34]. In
addition, TNF-α activates the PI3K/AKT signaling pathway
[35]. Therefore, we examined the relationship between
PI3K activity and P. gingivalis invasion in Ca9-22cells.
Ca9-22 cells were preincubated with wortmannin at 37°C
for 3 h and were then incubated with TNF-α. Treatment
with wortmannin also exhibited significant inhibitory
activity towards the invasion of P. gingivalis enhanced
by TNF-α (Figure 4). Several lines of evidence indicate
that cellular effects of TNF-α were elicited through
the activation of MAPK and NF-κB pathways. To ex-
plore the contribution of MAPK and NF-κB to TNF-
α-augmented invasion of P. gingivalis, we examined
whether P. gingivalis is able to invade Ca9-22 cells in
the presence or absence of MAPK inhibitors and an
NF-κB inhibitor. Ca9-22 cells were preincubated with
a p38 inhibitor (SB 203580, 5 μM), JNK inhibitor (SP
600125, 1 μM), ERK inhibitor (PD 98059, 5 μM) or
NF-κB inhibitor (PDTC, 5 μM) for 1 h and were then
incubated with TNF-α prior to addition of P. gingivalis.
SB 203580 and SP 600125 exhibited significant inhibitory
effects on the invasion of P. gingivalis into Ca9-22 cells
(Figure 5A). In contrast, PD 98059 did not prevent the
invasion of P. gingivalis augmented by TNF-α. PDTC
also exhibited significant inhibitory activity towards the
Figure 4 TNF-α augments endocytosis of P. gingivalis through
PI3K pathways. A PI3K inhibitor suppressed TNF-a-augmented invasion
of P. gingivalis in Ca9-22 cells. Ca9-22 cells were preincubated
with wortmannin (Wort, 300 nM) at 37°C for 3 h and were then
incubated with TNF-α. Viable P. gingivalis in the cells was determined
as described in Methods. (Means ± standard deviations [SD] [n = 3]).
††, P < 0.01 versus control + TNF-α (−); **, P < 0.01 versus
control + TNF-α (+).
Figure 5 TNF-α augments invasion of P. gingivalis through
NF-kB and MAPK pathways. (A) JNK and p38 inhibitors blocked
TNF-a-augmented invasion of P. gingivalis in Ca9-22 cells. Confluent
Ca9-22 cells were preincubated with MAP kinase inhibitors (p38
inhibitor (SB203580, 5 μM), JNK inhibitor (SP600125, 1 μM ) and ERK
inhibitor (PD98059, 5 μM)) at 37°C for 1 h and were then incu-
bated with TNF-α. Viable P. gingivalis in the cells was determined
as described in Methods. (Means ± standard deviations [SD] [n = 3]).
††, P < 0.01 versus control + TNF-α (−); **, P < 0.01 versus control +
TNF-α (+). (B) NF-κB inhibitor suppressed TNF-α-augmented
invasion of P. gingivalis in Ca9-22 cells. Ca9-22 cells were
preincubated with an NF-κB inhibitor (PDTC, 5 μM) at 37°C for 1 h
and were then incubated with TNF-α. Viable P. gingivalis in the cells
was determined as described in Methods. (Means ± standard deviations
[SD] [n = 3]). ††, P< 0.01 versus control + TNF-α (−); **, P< 0.01 versus
control + TNF-α (+).
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These results suggest that TNF-α augmented invasion of
P. gingivalis is mediated by p38 and JNK pathways and
activation of NF-κB.
ICAM-1 mediates invasion of P. gingivalis
Expression of ICAM-1 is required for invasion of some
bacteria in KB cells [36]. To determine whether ICAM-1
affects P. ginigvalis invasion into cells, we first examined
co-localization of P. gingivalis with ICAM-1 in cells.
Ca9-22 cells were incubated with P. gingivalis, and
localization of ICAM-1 and P. ginigvalis in the cells
was observed by a confocal laser scanning microscope.
ICAM-1 strongly expressed around the cell surface
was partially co-localized with P. gingivalis in the cells
(Figure 6A). We also examined the expression of ICAM-1
in TNF-α-treated Ca9-22 cells. Ca9-22 cells were treated
with or without TNF-α for 3 h. The cells were lysed
and expression of ICAM-1 was analyzed by Western
blotting. ICAM-1 was expressed in Ca9-22 cells with-
out TNF-α stimulation (Figure 6B). However, TNF-α
increased the expression of ICAM-1 in the cells. We
next examined whether ICAM-1 is associated with in-
vasion of P. gingivalis into the cells. Ca9-22 cells were
treated with TNF-α for 3 h, incubated with an anti-
ICAM-1 antibody or a control IgG antibody for anadditional 2 h, and then incubated with P. gingivalis.
Anti-ICAM-1 antibody suppressed invasion of P. gin-
givalis in the cells with or without TNF-α pretreat-
ment (Figure 6C). In contrast, P. gingivalis invasion
was not prevented by control IgG. These results sug-
gest that ICAM-1 is partially associated with invasion
of P. gingivalis into Ca9-22 cells.
Rab5 mediates endocytosis of P. gingivalis
Several studies have shown that Rab5 regulates events in
the fusion of bacteria-containing vacuoles and early
endosomes [37-39]. Therefore, we investigated whether
Rab5 mediates P. gingivalis invasion into cells. We first
Figure 6 ICAM-1 mediates invasion of P. gingivalis. (A) Ca9-22
cells were incubated with P. gingivalis for 1 h. The cells were then
stained using anti-ICAM-1 antibody. ICAM-1 is shown in green and
P. gingivalis is shown in red. Bars in each panel are 10 μm. (B) TNF-α
increased expression of ICAM-1 in Ca9-22 cells. Ca9-22 cells were
treated with 10 ng/ml of TNF-α for 3 h. The cells were lysed and the
expression of ICAM-1 and Rab5 was analyzed by Western blotting
with antibodies for each molecule. (C) Antibody to ICAM-1 inhibits
invasion of P. gingivalis in cells. Ca9-22 cells were treated with TNF-α
for 3 h and were then incubated with an anti-ICAM-1 antibody or a
control IgG antibody for 2 h. Viable P. gingivalis in the cells was
determined as described in Methods. (Means ± standard deviations
[SD] [n = 3]). ††, P < 0.01 versus control + TNF-α (−); **, P < 0.01
versus none + TNF-α (+).
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Western blotting. As shown in Figure 6B, Rab5 was
expressed in Ca9-22 cells. However, the level of expres-
sion was not affected by TNF-α. We next investigated
the role of Rab5 in P. gingivalis invasion using an siRNA
interference approach. Invasion assays were carried out
following transfection of Rab5-specific siRNA at a con-
centration of 100 pmol for 24 h. Then expression of
Rab5 in the cells was examined by Western blotting
(Figure 7A). The Rab5 siRNA-transfected Ca9-22 cellswere incubated with P. gingivalis for 1 h. Internalization
of P. gingivalis into the cells was reduced by silencing
the Rab5 gene (Figure 7B). To determine whether the
Rab5 affects P. ginigvalis invasion into cells, Ca9-22 cells
expressing GFP-Rab5 were treated with P. gingivalis,
and localization of Rab5 and P. ginigvalis in the cells
was observed by a confocal laser scanning microscope.
Transfected GFP-Rab5 was partially co-localized with
P. gingivalis in the cells (Figure 7C). These results sug-
gest that Rab5 is partially associated with invasion of
P. gingivalis into Ca9-22 cells.
Overexpression of the active form of Rab5 increased
invasion of P. gingivalis
Rab5 proteins switch between two distinct conforma-
tions, an active state characterized by binding to GTP
and an inactive state bound to GDP. To test whether the
activity of Rab5 affects P. ginigvalis invasion into cells,
Ca9-22 cells expressing fluorescent-labeled GFP alone
(control), GFP-Rab5 (S34N) (constitutively inactive
mutant), and GFP-Rab5 (Q79L) (constitutively active
mutant) were treated with P. gingivalis, and localization
of Rab5 and P. ginigvalis in the cells was observed by a
confocal laser scanning microscope. Transfected GFP-
Rab5 (Q79L) was co-localize with P. gingivalis in the cells
(Figure 7D). In contrast, GFP-Rab5 (S34N) did not co-
localize with P. gingivalis in the cells. We next trans-
fected vectors expressing GFP alone, GFP-Rab5 (S34N)
and GFP-Rab5 (Q79L) into Ca9-22 cells. The transfected
cells were then treated with P. ginigvalis and the levels of
invasion were compared among those cells. Internaliza-
tion of P. gingivalis into cells was increased in Ca9-22
cells expressing GFP-Rab5 (Q79L) compared to that in
Ca9-22 cells expressing GFP alone (Figure 7E). On the
other hand, overexpression of GFP-Rab5 (S34N) sup-
pressed invasion of P. gingivalis into the cells. These
results suggest that the activity of Rab5 influences P. gin-
givalis invasion.
TNF-α was associated with activity of Rab5 through the
JNK pathway
Several cytokines can control the activity of Rab5 to
regulate the rate of endocytosis through activating the
downstream signaling pathway. Therefore, we examined
whether activation of Rab5 was affected by MAP kinases
activated with TNF-α signals using a pull-down ap-
proach with a fusion protein that selectively binds GTP-
loaded Rab5 (GST-R5BD). The system selectively bound
GTP-bound Rab5 (active form of Rab5). Ca9-22 cells
were transfected with an expression vector with inserted
GFP-Rab5 gene. The transfected cells were preincubated
with MAP kinase inhibitors, including a p38 inhibitor
(SB203580), JNK inhibitor (SP600125) and ERK inhibitor
(PD98059), and were then incubated with TNF-α. The
Figure 7 Rab5 mediates endocytosis of P. gingivalis. (A) Ca9-22 cells were transfected with 100 pmol siRNA specific for Rab5 or control siRNA
using Lipofectamine 2000 reagent, as described by the manufacturer. Then expression of Rab5 in the cells was examined by Western blotting.
(B) Rab5 siRNA-transfected Ca9-22 cells were incubated with P. gingivalis for 1 h. Viable P. gingivalis in the cells was determined as described in
Methods. (Means ± standard deviations [SD] [n = 3]. **, P < 0.01 versus control siRNA. (C) Ca9-22 cells were transfected with expression vectors
with inserted genes of GFP alone and GFP-Rab5. The cells were incubated with P. gingivalis for 1 h. The cells were then stained using anti-P. gingivalis
antiserum. Each molecule was visualized as follows: GFP and GFP-Rab5 (green) and P. gingivalis (red). Bars in each panel are 10 μm. (D) Active form of
Rab5 colocalizes with P. gingivalis in Ca9-22 cells. Ca9-22 cells were transfected with vectors with inserted genes of GFP alone (control), GFP-Rab5
(S34N) (inactive form of Rab5), and GFP-Rab5 (Q79L) (active form of Rab5). The cells were incubated with P. gingivalis for 1 h. Then localization
of P. gingivalis and Rab5 in the cells was observed by a confocal laser scanning microscope. Each molecule was visualized as follows: GFP and
GFP-Rab5 (green) and P. gingivalis (red). Bars in each panel are 10 μm. (E) Overexpression of the active form of Rab5 increased invasion of
P. gingivalis in Ca9-22 cells. Ca9-22 cells were transfected with expression vectors with inserted genes of GFP alone (Control), GFP-Rab5 (S34N)
and GFP-Rab5 (Q79L). Viable P. gingivalis in the cells was determined as described in Methods. (Means ± standard deviations [SD] [n = 3]).
*, P < 0.05 versus control; **, P < 0.01 versus GFP alone.
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a GST-R5BD pull-down assay and was analyzed by
Western blotting. Level of the active form of Rab5induced by TNF-α was not affected by treatments
with SB203580 and PD98059. However, treatment
with SP60015 decreased the level of the active form
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sults suggest that JNK kinase mediates activation of
Rab5 by stimulation with TNF-α. Furthermore, we
invastigated whether NF-kB inhibition affects the acti-
vation of Rab5. Ca9-22 cells were transfected with an
expression vector with an inserted GFP-Rab5 gene.
The transfected cells were preincubated with an NF-κB
inhibitor (PDTC, 5 μM) at 37°C for 1 h and were then
incubated with TNF-α for 3 h. The active form of Rab5
in the cell lysates was subjected to a GST-R5BD pull-
down assay and was analyzed by Western blotting with
anti-GFP antibodies. Treatment with PDTC also did
not affect the level of the active form of Rab5 induced
by TNF- (Figure 9A, B). These results suggest thatFigure 8 TNF-α was associated with activity of Rab5 through the
JNK pathway. (A) Ca9-22 cells were transfected with an expression
vector with inserted GFP-Rab5 gene. The transfected cells were
preincubated with MAP kinase inhibitors, including a p38 inhibitor
(SB203580, 5 μM) (indicated as “SB”), JNK inhibitor (SP600125, 1 μM)
(indicated as “SP”) and ERK inhibitor (PD98059, 5 μM) (indicated as
“PD”), at 37°C for 1 h and were then incubated with TNF-α for 3 h.
The active form of Rab5 in the cell lysates was subjected to a
GST-R5BD pull-down assay and was analyzed by Western blotting
with anti-GFP antibodies as described in Methods. (B) Level of the
active form of Rab5-GTP was normalized to total GFP-Rab5 and
quantified by a densitometer. (Means ± deviations [SD] [n = 3]).
*, P < 0.05 versus control.NF-κB does not mediate activation of Rab5 by stimu-
lation with TNF-α.
TNF-α increased colocalization of P. gingivalis with
ICAM-1 and Rab5
Finally, we examined the relationships among P. gingiva-
lis, ICAM-1 and Rab5 in Ca9-22 cells. Ca9-22 cells were
transfected with expression vectors with inserted genesFigure 9 TNF-α was not associated with activity of Rab5
through the NF-κB pathway. (A) Ca9-22 cells were transfected
with an expression vector with an inserted GFP-Rab5 gene. The
transfected cells were preincubated with an NF-κB inhibitor (PDTC,
5 μM) at 37°C for 1 h and were then incubated with TNF-α for 3 h.
The active form of Rab5 in the cell lysates was subjected to a
GST-R5BD pull-down assay and was analyzed by Western blotting
with anti-GFP antibodies as described in Methods. (B) Level of the
active form of Rab5-GTP was normalized to total GFP-Rab5 and
quantified by a densitometer. (means ± deviations [SD] [n = 3]).
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ther incubated with P. gingivalis. The cells were then
stained using an anti-ICAM-1 antibody and antiserum
to P. gingivalis whole cells. A small amount of P. gingi-
valis that co-localized with ICAM-1 and GFP-Rab5 was
observed in Ca9-22 cells without TNF-α stimulation.
However, TNF-α stimulation increased co-localization of
P. gingivalis, ICAM-1 and GFP-Rab5 in Ca9-22 cells
(Figure 10). These findings suggest that TNF-α affects
the localization of Rab5 and ICAM-1 in cells and may
enhance internalization of P. gigivalis in the cells.
Discussion
TNF-α is a potent pleiotropic proinflammatory cytokine
and has been implicated in the pathogenesis of peri-
odontitis [12-14]. TNF-α was also shown to activate oral
epithelial cells. However, it was not known whether
TNF-α affects P. gingivalis invasion in epithelial cells. In
the present study, we demonstrated for the first time
that TNF-α augmented P. gingivalis invasion in oral epi-
thelial cells.
In this study, we showed that TNF-α activated Rab5
through JNK but not through p38 and ERK, although
TNF-α activates all of them. Activation of JNK is associ-
ated with the invasive process of P. gingivalis [1,40].
Therefore, JNK activated by TNF-α may mediate activa-
tion of Rab5 and may enhance internalization of P. gingi-
valis in cells. Rab5 is an important regulator of early
endosome fusion. Therefore, TNF-α may induce forma-
tion of early phagosomes by activating Rab5. On the
other hand, Bhattacharya et al. [41] demonstrated that
cytokines regulate bacterial phagocytosis through induc-
tion of Rab GTPases. They showed that IL-6 specifically
induces the expression of Rab5 and activates Salmonella
trafficking in cells through ERK activation. On the other
hand, IL-12 induced Rab7 expression through p38. An-
other study showed that activation of p38 MAPK regulates
endocytosis by regulating the activity of Rab5 accessoryFigure 10 TNF-α increased colocalization of P. gingivalis with
ICAM-1 and Rab5. Ca9-22 cells were transfected with expression
vectors with inserted genes of GFP-Rab5. The cells were treated with
TNF-α for 3 h and were further incubated with P. gingivalis for 1 h.
The cells were then stained using an anti-ICAM-1 antibody and
anti-P. gingivalis antisera. Each molecule was visualized as follows:
GFP-Rab5 (green), ICAM-1 (red), and P. gingivalis (blue).proteins such as Rab5-GDI, EEA1, and rabenosyn-5,
which are known to regulate membrane transport during
endocytosis. Several independent studies have also shown
that activation of ERK regulates endocytic traffic of mul-
tiple receptor systems, for example, 5-HT1A receptor, m1
muscarinic receptor, and opioid receptors [42-45]. These
findings suggest that activation of different kinases regu-
lates intracellular trafficking and also indicate that the
mechanism by which MAPKs regulate endocytosis may
differ depending on the stimulants and cells.
As shown in Figure 5B, the p38 inhibitor SB203580
blocked TNF-α-augmented P. gingivalis invasion in
Ca9-22 cells. However, SB203580 did not inhibit the
activation of Rab5 despite the fact that internalization
of P. gingivalis into the cells was partially blocked by
knock-down of Rab5a. TNF-α induced ICAM-1 expres-
sion through activating ERK/p38 MAPK [46]. There-
fore, p38 inhibition suppressed ICAM-1 expression
followed by decrease in P. gingivalis invasion. On the
other hand, Rab5 has three isoforms (A, B, and C) and
the isoforms are able to compensate for each other. As
we interfered with the expression of Rab5a but not that of
Rab5b and 5c, Rab5b and Rab5c, which were not blocked,
may compensate the function of Rab5a for bacterial
internalization.
P. gingivalis can enter Ca9-22 cells without TNF-α
stimulation (Figure 1A). Blockade of the TNF receptor
and inhibition of p38 and JNK did not completely inhibit
P. gingivalis invasion. These results suggest that P. gingi-
valis is also internalized in a TNF-α-independent man-
ner. P. gingivalis invades gingival epithelial cells without
any stimulation to the host cells. P. gingivalis fimbriae
interact with cell surface molecules such as integrins
and the interactions trigger colonization and internaliza-
tion of the bacteria in various cells [47,48]. Furthermore,
the trypsin-like cysteine protease gingipain produced by
P. gingivalis also plays an important role during P. gingi-
valis entry into cells [47]. P. gingivalis can enter host
cells by using these molecules without TNF-α stimula-
tion. However, TNF-α is increased in inflamed periodon-
tal tissues and gingival crevicular fluids. In those tissues,
P. gingivalis invasion is increased, and it promotes per-
sistent infection and avoids immune surveillance. The
cellular tropism of P. gingivalis depends in part upon the
fimbriase of the bacteria and the receptors of the host
cell. We used Ca9-22 cells as a model for gingival cell
infection. These cells were originally derived from hu-
man gingival carcinoma and phenotypically resemble
gingival epithelial cells. However, Ca9-22 cells may also
express some cell surface receptors that are different
from endogenous gingival cells. Thus our experimental
system is representative of bacteria-host interactions
in vivo, but not a perfect model We have little evidence
about that in vivo and further study is needed to make a
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of the phenomena.
Ca9-22 cells expressed TNFR-I but not TNFR-II
(Figure 2A). We also ascertained the expression of
TNFR-II after treatment with TNF-α in Ca9-22 cells.
However, TNF-α did not induce TNFR-II expression in
Ca9-22 cells. Therefore, we concluded that the effects of
TNF-α are mediated through TNFR-I. TNF-α activates
caspases and induces apoptosis in cells. However, C9-22
cells were alive during the experimental periods even
after stimulation with TNF-α (Additional file 1: Figure S2).
Therefore, we think that the apoptotic activity of TNF-α
towards host cells does not affect P. gingivalis invasion.
ICAM-1 as well as Rab5 was associated with TNF-α-
augmented P. gingivalis invasion (Figures 6 and 8). Ad-
hesion of P. gingivalis to host cells is multimodal and
involves the interaction of bacterial cell surface adhesins
with receptors expressed on the surfaces of epithelial
cells. Adhesion of P. gingivalis to host cells is mediated
by many extracellular components, including fimbriae,
proteases, hemagglutinins, and lipopolysaccharides (LPS).
Among the large array of virulence factors produced by
P. gingivalis, the major fimbriae (FimA), as well as cysteine
proteinases (gingipains), contribute to the attachment to
and invasion of oral epithelial cells [49,50]. On the other
hand, integrins can act as receptors for the integrin-
binding proteins of several bacterial species [51-53].
P. gingivalis also associates with β1 and α5β1 integrin het-
erodimers via FimA. αVβ3 integrin also mediates fimbriae
adhesion to epithelial cells [48]. In addition, carbohydrate
chains on epithelial cell membrane glycolipids have been
reported to act as receptors for P. gingivalis [54]. It has
been demonstrated that ICAM-1 is required for the inva-
sion of P. gingivalis into human oral epithelial cells [36].
Various cytokines including TNF-α induce expression of
ICAM-1 [55,56]. Therefore, ICAM-1 expresion and P. gin-
givalis invasion in periodontal sites may be associated with
the primary stages of the development and progression of
chronic periodontitis.
It has been demonstrated that a large number of intra-
cellular bacteria are present in IL-6-treated cells that
have an increasing amount of Rab5 [41]. These results
indicate that overexpression of Rab5 by cytokines may
promote the fusion of bacteria containing phagosomes
with early endosomes and thereby inhibit their transport
to lysosomes and may help in prolongation of bacterial
survival in host cells and thus establish a chronic infection
that could exacerbate the immune response. At periodon-
tal sites, such phenomena could occur. Periodontopathic
bacteria induce various cytokines including TNF-α. It
has been shown that of TNF-α is upregulated in peri-
odontitis, e.g., in gingival crevicular fluid [23] and in
gingival tissues [24]. Therefore, periodontopathic bac-
teria including P. gingivalis induce the production ofcytokines including TNF-α in periodontal tissues. Ex-
cess TNF-α in periodontal tissues activates gingival
epithelial cells and increases the possibility of P. gingi-
valis invasion in the cells, resulting in persistence of
P. ginigvalis infection and prolongation of immune re-
sponses in periodontal tissues.
Conclusions
We demonstrated that P. ginigvalis invasion into human
gingival epithelial cells was enhanced by stimulation with
TNF-α. TNF-α in periodontal tissues, the production of
which is induced by plaque bacteria including P. gingivlis
and is increased by diabetes, may lead to persistent in-
fection of P. ginigvalis and prolongation of immune re-
sponses in periodontal tissues.
Methods
Bacterial strains and growth conditions
P. gingivalis ATCC 33277 was used as a wild-type strain
in this study. This strain was grown at 37°C under anaer-
obic conditions on 5% horse blood agar plates (Poa Media,
Eiken Chemical Co., Ltd., Tokyo, Japan) and in 30 mg/ml
trypticase soy broth (BD Biosciences, SanJose, CA) supple-
mented with 2.5 mg/ml yeast extract (BD Biosciences),
5 μg/ml hemin and 5 μg/ml menadione. Bacterial growth
was monitored by measuring the optical density at 660 nm
(OD660). For invasion assays, an inoculum with an infec-
tion ratio (multiplicity of infection [MOI]) of 100 bacteria
per cell was added to the cell culture medium.
Cell culture
The human gingival epithelial cell line Ca9-22 was ob-
tained from RIKEN Bioresource Center (Ibaraki, Japan).
Ca9-22 cells were cultured under standard conditions in
Eagle's minimal essential medium (E-MEM; Wako Pure
Chemical Industries, Ltd., Osaka, Japan) containing 10%
fetal bovine serum (FBS), 1% penicillin and streptomycin
at 37°C in a humidified atmosphere of 5% CO2. The
monocytic cell line THP-1 was obtained from Japanese
Collection of Research Bioresources Cell Bank (Osaka,
Japan). THP-1 cells were cultured under standard condi-
tions in Roswell Park Memorial Institute (RPMI) 1640
Medium (Invitrogen, Carlsbad, CA) containing 10% FBS,
1% penicillin and streptomycin at 37°C in a humidified
atmosphere of 5% CO2.
Antibodies
Antibodies were obtained from the following sources:
antiserum for P. gingivalis whole cells was kindly donated
by Dr. Fuminobu Yoshimura (Aichi-gakuin University,
Aichi, Japan); mouse monoclonal antibody specific for
ICAM-1, goat polyclonal antibody specific for ICAM-1,
mouse monoclonal antibody specific for TNFRI, mouse
monoclonal antibody specific for TNFRII and mouse
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MN); mouse monoclonal antibody specific for Rab5
(BD Biosciences); rabbit polyclonal antibody specific
for ICAM-1 (Santa Cruz Biotechnology, Dallas, TX); goat
IgG (Alpha Diagnostic Intl. Inc., San Antonio, TX); mouse
monoclonal antibody specific for β-actin (Biovision Inc.,
Milpitas, CA); anti-rabbit IgG-Alexa 555 and anti-rabbit
IgG-Alexa 633 (Invitrogen); mouse monoclonal antibody
specific for GFP (Novus Biologicals, Littleton, CO),
anti-mouse IgG-HRP, anti-rabbit IgG-HRP and mouse
monoclonal antibody specific for β-actin (Cell Signaling
Technology, Danvers, MA).
Vector constructs
GFP-Rab5Q79L, GFP-Rab5WT, and GFP-Rab5S34N in
pcDNA3 constructs were kindly provided by Dr. Yuji
Yamamoto (Tokyo University of Agriculture, Tokyo, Japan)
[57,58]. The GST-R5BD vector was kindly donated by
Dr. Guangpu Li (University of Oklahoma Health Science
Center, Oklahoma City, OK).
P. gingivalis invasion assay
Invasion of bacteria was quantitated by a standard anti-
biotic protection assay as described previously [59].
Briefly, Ca9-22 cells were seeded in 12-well flat-bottom
culture plates and were incubated overnight before ad-
ministration of P. gingivalis. The cells then were washed
twice with phosphate-buffered saline (PBS) and incu-
bated for a further 1 h in OPTI-MEM (Invitrogen) with-
out antibiotics. The cells were treated with 10 ng/ml of
recombinant human TNF-α (Wako) for 3 h. P. gingivalis
suspended in OPTI-MEM was added to the Ca9-22 cells
at an MOI of 1:100 and further incubated at 37°C in 5%
CO2 for 1 h. Unattached bacteria were removed by
washing with PBS three times. OPTI-MEM containing
200 μg/ml of metronidazole and 300 μg/ml of gentami-
cin was added to the plates and they were incubated for
1 h. The cells were washed twice with PBS, and then
1 ml of sterile distilled water per well was added and the
cells were suspended persistently by pipetting to disrupt
them. The lysates were serially diluted and plated on 5%
horse blood agar plates (Poa Media, Eiken Chemical)
and then incubated anaerobically at 37°C for 10 days.
Colony-forming units (CFU) of invasive P. gingivalis in
cells were then enumerated.
Silencing of Rab5 gene
Ca9-22 cells were transfected with 100 pmol siRNA spe-
cific for Rab5 (RAB5A-HSS108978, Invitrogen) or control
siRNA (Stealth™ RNAi Negative Control Medium GC
Duplex, Invitrogen) using Lipofectamine 2000 reagent, as
described by the manufacturer (Invitrogen). Then, expres-
sion of Rab5 in the cells was examined by Western blotting
using a monoclonal antibody to Rab5. Next, Rab5 siRNA-transfected Ca9-22 cells were incubated with P. gingivalis
ATCC 33277 (MOI =100) for 1 h. Viable P. gingivalis in
the cells was determined as described above.
Immunostaining
Treated Ca9-22 cells were fixed with 4% formaldehyde
for 10 min. Nonspecific binding of antibodies was
blocked by incubation with 5% sheep serum in 10 mM
Tris pH 7.6, 150 mM NaCl, and 0.05% Tween20 (TBS-T)
for 1 h, and then the cells were incubated overnight at 4°C
with a primary antibody (antiserum for P. gingivalis whole
cells, mouse monoclonal antibody specific for ICAM-1) in
TBS-T. After washing with buffer A (10 mM Tris pH 7.6,
300 mM NaCl, and 0.5% Tween20) 6 times, the cells were
treated with a secondary antibody (anti-rabbit IgG-Alexa
555 or anti-mouse IgG-Alexa 555 and anti-rabbit IgG-
Alexa 633) in buffer A for 1 h. Cells were then observed by
a confocal laser scanning microscope (Leica microsystems,
Welzlar, Germany). Some Ca9-22 cells were transfected
with vectors containing genes of GFP alone (control), GFP-
Rab5 (S34N) (inactive form of Rab5), and GFP-Rab5
(Q79L) (active form of Rab5). To clarify whether P. gingi-
valis cells are in the epithelial cells, a z-series with 0.5 μm-
intervals was scanned and images of the x-z and y-z planes
were reconstructed with the orthogonal section tool.
Western blotting
TNF-α-treated and non-treated Ca9-22 cells and THP-1
cells were lysed in SDS-PAGE sample buffer, separated by
SDS-PAGE, and transferred onto Immobilon-P Transfer
Membranes (Millipore, Billerica, MA). The membranes
were blocked with PVDF Blocking Reagent for Can Get
Signal (Toyobo) in TBS-T for 1 h at room temperature and
then incubated with antibodies to TNFRI, TNFRII, Rab5
and ICAM-1 overnight at 4°C. After washing 3 times with
TBS-T, the membranes were incubated with horseradish-
peroxidase-conjugated anti-rabbit or mouse IgG antibodies
in Can Get Signal® Immunoreaction Enhancer Solution.
The membranes were washed 3 times with TBS-T and then
immunoreactive bands were visualized using ECL Western
Blotting detection reagents (GE Healthcare, Uppsala,
Sweden) or Immuno Star LD (Wako). The membranes
were stripped and probed with anti-β-actin antibodies as a
loading control.
GST-R5BD pull-down assay
The GST-R5BD pull-down assay was based on the method
described by Liu et al. [60]. Ca9-22 cells were transfected
with GFP-Rab5 (WT) using Lipofectamine 2000 reagent,
as described by the manufacturer (Invitrogen). The trans-
fectants were pretreated with MAP kinase inhibitors, in-
cluding a p38 inhibitor (SB203580, 5 μM), JNK inhibitor
(SP600125, 1 μM), and ERK inhibitor (PD98059, 5 μM)
(Calbiochem, San Diego, CA), or with an NF-κB inhibitor
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1 h followed by stimulating with 10 ng/ml TNF-α for 3 h.
Thereafter, cell extracts were prepared in lysis buffer con-
taining 25 mM HEPES pH 7.4, 100 mM NaCl, 5 mM
MgCl2, 0.1% Nonidet P-40, 2% glycerol, 1 mM dithio-
threitol, and protease inhibitors. The cell lysates were
centrifuged at 13,000 × g for 10 min at 4°C, and then
the supernatants were incubated with 20 μl of GST-
R5BD bound to glutathione-Sepharose 4B beads for
10 min at 4°C under rotation. Thereafter, beads were
collected and washed 3 times with lysis buffer. Samples
were re-suspended in SDS sample buffer and analyzed by
Western blotting.
Measurement of cell viability
Cell viability was assessed by the trypan blue staining
assay. Ca9-22 cells were preincubated with wortmannin
(Wort, 300 nM) for 3 h or with actinomycin D (Act D,
1 μg/ml ), cycloheximide (CHX, 1 μg/ml ), NF-κB inhibi-
tor (PDTC, 5 μM), MAP kinase inhibitors, including a p38
inhibitor (SB203580, 5 μM), JNK inhibitor (SP600125,
1 μM) and ERK inhibitor (PD98059, 5 μM), at 37°C
for 1 h and were then incubated with TNF-α for 3 h.
Viability of the cells was determined by an exclusion test
with trypan blue. Each measurement was repeated three
times independently. Those compounds were not toxic
to the cells. (Additional file 2: Figure S1).
Statistical analyses
All experiments were performed in triplicate for each
condition and repeated at least three times. Statistical
analyses were performed using an unpaired Student’s
t test. Multiple comparisons were performed by one-
way analysis of variance and the Bonferroni or Dunn
method, with results presented as the mean ± standard
deviation. P-values less than 0.05 were considered statisti-
cally significant.
Additional files
Additional file 1: Figure S2. Numbers of alive P. gingivalis bacteria in
Ca9-22 cell cultures. The numbers of intracellular and extracellular
P. gingivalis were determined in Ca9-22 cells. Ca9-22 cells were treated
with 10 ng/ml TNF-α for 3 h. The cells were infected with P. gingivalis (MOI
100) for 1 h. The cells were further cultured in media containing antibiotics
for various time periods to kill extracellular bacteria. Then the cells were
incubated in antibiotics-free media for 0–48 h, and the numbers of
intracellular and extracellular bacteria were determined. The assays were
carried out in triplicate as described in Methods. * and **, significantly
different (P < 0.05 and P < 0.01, respectively) from the mean value for
TNF (−). Error bars indicate standard errors of the means.
Additional file 2: Figure S1. Cytotoxicity of chemical compounds used in
this study. Ca9-22 cells were preincubated with wortmannin (Wort, 300 nM)
for 3 h or with actinomycin D (Act D, 1 μg/ml ), cycloheximide (CHX,
1 μg/ml), an NF-κB inhibitor (PDTC, 5 μM) and MAP kinase inhibitors,
including a p38 inhibitor (SB203580, 5 μM) (indicated as “SB”), JNK
inhibitor (SP600125, 1 μM) (indicated as “SP”) and ERK inhibitor(PD98059, 5 μM) (indicated as “PD”), at 37°C for 1 h and were then
incubated with TNF-α for 3 h. Viability of the cells was determined
by an exclusion test with trypan blue.
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